Pricing Log in Create free account
Saturday 17 October 2026 Export DXCM’s income statement to Excel — free account

DexCom, Inc.

DXCM Healthcare Medical Devices

DexCom, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 15.6% from fiscal 2024. In the quarter to June 2026, revenue grew 13.1%, EPS grew 41.3%, free cash flow fell 11.7% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

86.06 1.65 −1.88%
Market cap
$33.1B
P/E
33.2×
Fwd P/E
29.8×
Dividend yield
—
F-score
8/9
Altman Z
6.43
Beneish M
−2.70
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

DexCom, Inc. (DXCM) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, DexCom, Inc. (DXCM) trades at a P/S ratio of 6.6×. Over the past ten years it has ranged from 4.6× (April 2026) to 27.2× (November 2021); the current reading is higher than 10% of that period. That is above the Medical Devices industry median of 2.3× and above the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 5.6× (26.81%)
FY2024 7.6× (42.13%)
FY2023 13.1× (14.57%)
FY2022 15.4× (27.62%)
FY2021 21.2× 17.13%
FY2020 18.1× 34.13%
FY2019 13.5× 31.82%
FY2018 10.2× 47.03%
FY2017 7.0× (17.97%)
FY2016 8.5× (47.77%)

Quarterly newest first

Period P/S ratio Change
Jun 2026 5.2× 3.20%
Mar 2026 5.0× (9.64%)
Dec 2025 5.6× (4.68%)
Sep 2025 5.8× (26.77%)
42 more quarters

Against its own ten years

Low 4.6× High 27.2×
Ten-year median 12.6×
Current reading's percentile 11

P/S ratio against peers

Company P/S ratio
PHG Koninklijke Philips N.V. compare 1.2×
SNN Smith & Nephew SNATS, Inc. compare 1.2×
GEHC GE HealthCare Technologies Inc. compare 1.5×
ZBH Zimmer Biomet Holdings, Inc. compare 2.1×
BSX Boston Scientific Corporation compare 3.1×
STE STERIS plc compare 3.6×
DXCM DexCom, Inc. 6.6×
EW Edwards Lifesciences Corporation compare 7.7×
PEN Penumbra, Inc. compare 8.4×
Medical Devices industry median 2.3×
Healthcare sector median 3.4×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on DXCM